NURS 251: PHARMACOLOGY COMPREHENSIVE
FINAL EXAM
Modules 1–10 Review & Final Assessment
200 Practice Questions with Detailed Clinical Rationales
Module 1: Introduction to Pharmacology, Pharmacokinetics, &
Pharmacodynamics
Question 1:
Q1: A patient is prescribed a drug with a narrow therapeutic index.
Which nursing intervention is most critical?
A) Monitor serum drug levels routinely
B) Administer the drug only with meals
C) Encourage high fluid intake
D) Assess liver enzyme function weekly
Correct Answer: A
Clinical Rationale: A narrow therapeutic index means there is a
narrow margin between therapeutic and toxic effects. Routine serum
drug monitoring is essential to prevent toxicity.
Q2: Which pharmacokinetic parameter describes the percentage of
administered drug that reaches the systemic circulation?
A) Half-life
B) Bioavailability
C) First-pass effect
, D) Volume of distribution
Correct Answer: B
Clinical Rationale: Bioavailability refers to the fraction of an
administered drug that reaches systemic circulation unchanged.
Q3: A drug administered via the sublingual route bypasses which
primary physiological process?
A) Renal excretion
B) Glomerular filtration
C) Hepatic first-pass metabolism
D) Cellular receptor binding
Correct Answer: C
Clinical Rationale: Sublingual medications are absorbed directly
into systemic circulation through oral mucosa, bypassing the portal
circulation and hepatic first-pass metabolism.
Q4: Pharmacodynamics primarily studies which of the following aspects
of drug action?
A) How the body metabolizes drugs
B) What drugs do to the body and their mechanism of action
C) The rate of renal clearance
D) Absorption across the intestinal wall
, Correct Answer: B
Clinical Rationale: Pharmacodynamics is the study of biochemical
and physiological effects of drugs and their mechanisms of action
(what drugs do to the body).
Q5: An agonist drug is best defined as a medication that:
A) Blocks receptor activation
B) Binds to a receptor and produces a biological response
C) Accelerates hepatic enzyme degradation
D) Competes irreversibly with endogenous ligands
Correct Answer: B
Clinical Rationale: Agonists bind to receptors and mimic
endogenous regulatory molecules, activating the receptor to produce
a biological response.
Q6: Which factor most significantly decreases drug metabolism in
elderly patients?
A) Decreased gastric acidity
B) Increased glomerular filtration rate
C) Decreased hepatic blood flow and microsomal enzyme activity
D) Increased plasma protein binding
Correct Answer: C
Clinical Rationale: Aging is associated with reduced hepatic blood
, flow and diminished CYP450 enzyme activity, slowing drug
metabolism.
Q7: The half-life (t1/2) of a medication is defined as the time required
for:
A) Peak plasma concentration to be reached
B) The drug to be completely eliminated from the body
C) The plasma concentration of the drug to decrease by 50%
D) The therapeutic effect to begin
Correct Answer: C
Clinical Rationale: Half-life is the time required for the amount of
drug in the body or plasma concentration to decline by 50%.
Q8: When two drugs with identical mechanisms are given together, the
combined effect is typically:
A) Antagonistic
B) Additive or synergistic
C) Neutralized
D) Inactive
Correct Answer: B
Clinical Rationale: Combining drugs with similar mechanisms
results in additive or synergistic therapeutic and adverse effects.
FINAL EXAM
Modules 1–10 Review & Final Assessment
200 Practice Questions with Detailed Clinical Rationales
Module 1: Introduction to Pharmacology, Pharmacokinetics, &
Pharmacodynamics
Question 1:
Q1: A patient is prescribed a drug with a narrow therapeutic index.
Which nursing intervention is most critical?
A) Monitor serum drug levels routinely
B) Administer the drug only with meals
C) Encourage high fluid intake
D) Assess liver enzyme function weekly
Correct Answer: A
Clinical Rationale: A narrow therapeutic index means there is a
narrow margin between therapeutic and toxic effects. Routine serum
drug monitoring is essential to prevent toxicity.
Q2: Which pharmacokinetic parameter describes the percentage of
administered drug that reaches the systemic circulation?
A) Half-life
B) Bioavailability
C) First-pass effect
, D) Volume of distribution
Correct Answer: B
Clinical Rationale: Bioavailability refers to the fraction of an
administered drug that reaches systemic circulation unchanged.
Q3: A drug administered via the sublingual route bypasses which
primary physiological process?
A) Renal excretion
B) Glomerular filtration
C) Hepatic first-pass metabolism
D) Cellular receptor binding
Correct Answer: C
Clinical Rationale: Sublingual medications are absorbed directly
into systemic circulation through oral mucosa, bypassing the portal
circulation and hepatic first-pass metabolism.
Q4: Pharmacodynamics primarily studies which of the following aspects
of drug action?
A) How the body metabolizes drugs
B) What drugs do to the body and their mechanism of action
C) The rate of renal clearance
D) Absorption across the intestinal wall
, Correct Answer: B
Clinical Rationale: Pharmacodynamics is the study of biochemical
and physiological effects of drugs and their mechanisms of action
(what drugs do to the body).
Q5: An agonist drug is best defined as a medication that:
A) Blocks receptor activation
B) Binds to a receptor and produces a biological response
C) Accelerates hepatic enzyme degradation
D) Competes irreversibly with endogenous ligands
Correct Answer: B
Clinical Rationale: Agonists bind to receptors and mimic
endogenous regulatory molecules, activating the receptor to produce
a biological response.
Q6: Which factor most significantly decreases drug metabolism in
elderly patients?
A) Decreased gastric acidity
B) Increased glomerular filtration rate
C) Decreased hepatic blood flow and microsomal enzyme activity
D) Increased plasma protein binding
Correct Answer: C
Clinical Rationale: Aging is associated with reduced hepatic blood
, flow and diminished CYP450 enzyme activity, slowing drug
metabolism.
Q7: The half-life (t1/2) of a medication is defined as the time required
for:
A) Peak plasma concentration to be reached
B) The drug to be completely eliminated from the body
C) The plasma concentration of the drug to decrease by 50%
D) The therapeutic effect to begin
Correct Answer: C
Clinical Rationale: Half-life is the time required for the amount of
drug in the body or plasma concentration to decline by 50%.
Q8: When two drugs with identical mechanisms are given together, the
combined effect is typically:
A) Antagonistic
B) Additive or synergistic
C) Neutralized
D) Inactive
Correct Answer: B
Clinical Rationale: Combining drugs with similar mechanisms
results in additive or synergistic therapeutic and adverse effects.
